Skip to main content
Erschienen in: Supportive Care in Cancer 9/2015

01.09.2015 | Original Article

Predictors of functional capacity in colorectal cancer patients

verfasst von: Murat Tomruk, Didem Karadibak, Tuğba Yavuzşen, Tülay Akman

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study is to determine the predictors of functional capacity and explore the relationship between functional capacity, performance status, fatigue, quality of life, anxiety, and depression in colorectal cancer (CRC) patients.

Methods

Forty-two patients diagnosed as stage II–III CRC according to tumor, node, metastasis (TNM) classification were included the study. Functional capacity, performance status, fatigue, quality of life, anxiety, and depression of CRC patients were assessed using six-minute walk distance (6MWD) in the six-minute walk test (6MWT), Eastern Cooperative Oncology Group Performance Status (ECOG-PS), Brief Fatigue Inventory (BFI), Functional Assessment of Cancer Therapy-Colorectal (FACT-C), and Hospital Anxiety and Depression Scale (HADS), respectively. A multiple linear regression model was used to identify independent predictors of functional capacity.

Results

The six-minute walk distance (6MWD) was intermediately and negatively correlated with ECOG-PS score (p = 0.001, r = −0.415), BFI-impact of fatigue on daily functioning score (p = 0.013, r = −0.379), and age (p = 0.040, r = −0.319). An intermediate and positive correlation was found between 6MWD and FACT-C score (p = 0.016, r = 0.369). The multiple regression analysis revealed that only ECOG-PS score was significant and independent predictor of the 6MWD, accounted for 34.8 % of the variance.

Conclusion

Performance status was found to be the only significant predictor of functional capacity in this study. Assessing performance status may have an essential role in order to predict functional capacity in CRC patients. Future studies that include a larger sample size would more clearly elucidate the predictors and relationships of functional capacity.
Literatur
1.
Zurück zum Zitat IARC (2008) GLOBOCAN database. 2008, IARC IARC (2008) GLOBOCAN database. 2008, IARC
3.
Zurück zum Zitat Sökmen S (2004) Kolorektal Kanserde Prognoz, Kolorektal Özel Sayısı. Turk J Surg 9:57–65 Sökmen S (2004) Kolorektal Kanserde Prognoz, Kolorektal Özel Sayısı. Turk J Surg 9:57–65
4.
Zurück zum Zitat Matheson L (1996) Functional capacity evaluation. In: Andersson G, Demeter S, Smith G (eds) Disability evaluation. Mosby Yearbook, Chicago Matheson L (1996) Functional capacity evaluation. In: Andersson G, Demeter S, Smith G (eds) Disability evaluation. Mosby Yearbook, Chicago
5.
Zurück zum Zitat Gibbons RJ, Ritchie JL, Cardiology ACo, Guidelines AHATFoP (2002) ACC/AHA 2002 guideline update for exercise testing. American College of Cardiology Gibbons RJ, Ritchie JL, Cardiology ACo, Guidelines AHATFoP (2002) ACC/AHA 2002 guideline update for exercise testing. American College of Cardiology
6.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. (trans: Committee on cancer survivorship: improving care and quality of life NCPB). Institute of Medicine and National Research Council, Washington DC Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. (trans: Committee on cancer survivorship: improving care and quality of life NCPB). Institute of Medicine and National Research Council, Washington DC
7.
Zurück zum Zitat Travers J, Dudgeon DJ, Amjadi K, McBride I, Dillon K, Laveneziana P, Ofir D, Webb KA, O’Donnell DE (2008) Mechanisms of exertional dyspnea in patients with cancer. J Appl Physiol (1985) 104 (1):57–66. doi:10.1152/japplphysiol.00653.2007 Travers J, Dudgeon DJ, Amjadi K, McBride I, Dillon K, Laveneziana P, Ofir D, Webb KA, O’Donnell DE (2008) Mechanisms of exertional dyspnea in patients with cancer. J Appl Physiol (1985) 104 (1):57–66. doi:10.​1152/​japplphysiol.​00653.​2007
8.
Zurück zum Zitat Courneya KS, Friedenreich CM (2001) Framework PEACE: an organizational model for examining physical exercise across the cancer experience. Ann Behav Med 23(4):263–272PubMedCrossRef Courneya KS, Friedenreich CM (2001) Framework PEACE: an organizational model for examining physical exercise across the cancer experience. Ann Behav Med 23(4):263–272PubMedCrossRef
9.
Zurück zum Zitat Norton K (2005) Sports Medicine Australia (SMA) pre-exercise screening system 2005. Sports Medicine Australia, Canberra Norton K (2005) Sports Medicine Australia (SMA) pre-exercise screening system 2005. Sports Medicine Australia, Canberra
10.
Zurück zum Zitat ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Resp Crit Care 166(1):111–117. doi:10.1164/ajrccm.166.1.at1102 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Resp Crit Care 166(1):111–117. doi:10.​1164/​ajrccm.​166.​1.​at1102
11.
Zurück zum Zitat Enright PL (2003) The six-minute walk test. Resp Care 48(8):783–785 Enright PL (2003) The six-minute walk test. Resp Care 48(8):783–785
13.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol Canc 5(6):649–655CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol Canc 5(6):649–655CrossRef
14.
Zurück zum Zitat Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer (Oxford, England : 1990) 32A(7):1135–1141CrossRef Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer (Oxford, England : 1990) 32A(7):1135–1141CrossRef
15.
Zurück zum Zitat Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196PubMedCrossRef Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196PubMedCrossRef
16.
Zurück zum Zitat Azak A, Çınar S (2005) Lenfomalı (hodgkin ve non-hodgkin) hastalarda yorgunluk sendromu ve etkileyen faktörler. Turk J Hematol Oncol 15:78–83 Azak A, Çınar S (2005) Lenfomalı (hodgkin ve non-hodgkin) hastalarda yorgunluk sendromu ve etkileyen faktörler. Turk J Hematol Oncol 15:78–83
17.
Zurück zum Zitat Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D (1999) Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res Int Journal Qual Life Aspects Treatment, Care and Rehab 8(3):181–195CrossRef Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D (1999) Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res Int Journal Qual Life Aspects Treatment, Care and Rehab 8(3):181–195CrossRef
18.
Zurück zum Zitat Özgüven HD, Köker S, Canat S (1997) Hastane anksiyete ve depresyon ölçeği’nin bir Ankara örnekleminde geçerlik ve güvenirliği. 3P (Psikiyatri Psikoloji Psikofarmakoloji) Dergisi 5:197–201 Özgüven HD, Köker S, Canat S (1997) Hastane anksiyete ve depresyon ölçeği’nin bir Ankara örnekleminde geçerlik ve güvenirliği. 3P (Psikiyatri Psikoloji Psikofarmakoloji) Dergisi 5:197–201
19.
Zurück zum Zitat Aydemir Ö, Köroğlu E (2006) Psikiyatride kullanılan klinik ölçekler. Hekimler Yayın Birliği, Ankara Aydemir Ö, Köroğlu E (2006) Psikiyatride kullanılan klinik ölçekler. Hekimler Yayın Birliği, Ankara
20.
Zurück zum Zitat Aksakoğlu G (2006) Sağlıkta Araştırma ve Çözümleme, İkinci Yazım. D.E.Ü. Rektörlük Basım Evi, İzmir Aksakoğlu G (2006) Sağlıkta Araştırma ve Çözümleme, İkinci Yazım. D.E.Ü. Rektörlük Basım Evi, İzmir
22.
Zurück zum Zitat Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS (2009) Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J Neuro Oncol 94(1):79–85. doi:10.1007/s11060-009-9803-x CrossRef Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS (2009) Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. J Neuro Oncol 94(1):79–85. doi:10.​1007/​s11060-009-9803-x CrossRef
23.
Zurück zum Zitat Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM (2006) Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Resp Crit Care 174(6):659–664. doi:10.1164/rccm.200604-520OC CrossRef Lederer DJ, Arcasoy SM, Wilt JS, D'Ovidio F, Sonett JR, Kawut SM (2006) Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Resp Crit Care 174(6):659–664. doi:10.​1164/​rccm.​200604-520OC CrossRef
24.
Zurück zum Zitat Shah MR, Hasselblad V, Gheorghiade M, Adams KF Jr, Swedberg K, Califf RM, O'Connor CM (2001) Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 88(9):987–993PubMedCrossRef Shah MR, Hasselblad V, Gheorghiade M, Adams KF Jr, Swedberg K, Califf RM, O'Connor CM (2001) Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 88(9):987–993PubMedCrossRef
26.
Zurück zum Zitat Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim do J, Vassiliou MC, Feldman LS (2013) Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc 27(4):1072–1082. doi:10.1007/s00464-012-2560-5 PubMedCrossRef Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim do J, Vassiliou MC, Feldman LS (2013) Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc 27(4):1072–1082. doi:10.​1007/​s00464-012-2560-5 PubMedCrossRef
27.
Zurück zum Zitat Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Supp Care Canc Offic J Multi Assoc Supp Care Canc 14(12):1205–1212. doi:10.1007/s00520-006-0080-3 Gustafsson M, Edvardsson T, Ahlstrom G (2006) The relationship between function, quality of life and coping in patients with low-grade gliomas. Supp Care Canc Offic J Multi Assoc Supp Care Canc 14(12):1205–1212. doi:10.​1007/​s00520-006-0080-3
29.
Zurück zum Zitat Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28(3):465–470PubMed
30.
Zurück zum Zitat Sutradhar R, Atzema C, Seow H, Earle C, Porter J, Howell D, Dudgeon D, Barbera L (2014) Is performance status associated with symptom scores? A population-based longitudinal study among cancer outpatients. J Palliat Care 30(2):99–107PubMed Sutradhar R, Atzema C, Seow H, Earle C, Porter J, Howell D, Dudgeon D, Barbera L (2014) Is performance status associated with symptom scores? A population-based longitudinal study among cancer outpatients. J Palliat Care 30(2):99–107PubMed
32.
33.
Zurück zum Zitat Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Supp Care Canc Offic J Multi Assoc Supp Care Canc 8(3):175–179 Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Supp Care Canc Offic J Multi Assoc Supp Care Canc 8(3):175–179
34.
Zurück zum Zitat Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM (2000) Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78(3 Pt 1):302–308. doi:10.1006/gyno.2000.5908 PubMedCrossRef Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM (2000) Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78(3 Pt 1):302–308. doi:10.​1006/​gyno.​2000.​5908 PubMedCrossRef
35.
Zurück zum Zitat Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, West C, Cho M, Bank A (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33(5):E79–E89. doi:10.1188/06.onf. e79-e89 PubMedCrossRef Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, West C, Cho M, Bank A (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33(5):E79–E89. doi:10.​1188/​06.​onf.​ e79-e89 PubMedCrossRef
37.
38.
Zurück zum Zitat Turner J, Hayes S, Reul-Hirche H (2004) Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol 86(3):141–146. doi:10.1002/jso.20065 PubMedCrossRef Turner J, Hayes S, Reul-Hirche H (2004) Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol 86(3):141–146. doi:10.​1002/​jso.​20065 PubMedCrossRef
39.
Zurück zum Zitat Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R (1999) Fatigue in advanced cancer: a prospective controlled cross-sectional study. Brit J Canc 79(9–10):1479–1486. doi:10.1038/sj.bjc.6690236 CrossRef Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R (1999) Fatigue in advanced cancer: a prospective controlled cross-sectional study. Brit J Canc 79(9–10):1479–1486. doi:10.​1038/​sj.​bjc.​6690236 CrossRef
40.
Zurück zum Zitat Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV (2013) Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer (Oxford, England : 1990) 49(8):1957–1966. doi:10.1016/j.ejca.2013.01.012 CrossRef Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV (2013) Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer (Oxford, England : 1990) 49(8):1957–1966. doi:10.​1016/​j.​ejca.​2013.​01.​012 CrossRef
41.
Zurück zum Zitat Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (Oxford, England : 1990) 38(10):1351–1357CrossRef Maisey NR, Norman A, Watson M, Allen MJ, Hill ME, Cunningham D (2002) Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (Oxford, England : 1990) 38(10):1351–1357CrossRef
42.
Zurück zum Zitat Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5(5):353–360PubMedCrossRef Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5(5):353–360PubMedCrossRef
43.
Zurück zum Zitat Jacobsen P, Weitzner M (2003) Evaluating the relationship of fatigue to depression and anxiety in cancer patients. In: Portenoy R, Bruera E (eds) Issues in palliative care research. Oxford University Press, New York, pp 127–150 Jacobsen P, Weitzner M (2003) Evaluating the relationship of fatigue to depression and anxiety in cancer patients. In: Portenoy R, Bruera E (eds) Issues in palliative care research. Oxford University Press, New York, pp 127–150
44.
Zurück zum Zitat Winell J, Roth AJ (2004) Depression in cancer patients. Oncology (Williston Park, NY) 18(12):1554–1560, discussion 1561-1552 Winell J, Roth AJ (2004) Depression in cancer patients. Oncology (Williston Park, NY) 18(12):1554–1560, discussion 1561-1552
45.
Zurück zum Zitat Piper B (2003) Fatigue. In: Kohlman-Carrieri V, Lindsey A, West C (eds) Pathophysiological phenomena in nursing, human responses to illness, 3rd edn. Saunders Company, pp 209–235 Piper B (2003) Fatigue. In: Kohlman-Carrieri V, Lindsey A, West C (eds) Pathophysiological phenomena in nursing, human responses to illness, 3rd edn. Saunders Company, pp 209–235
Metadaten
Titel
Predictors of functional capacity in colorectal cancer patients
verfasst von
Murat Tomruk
Didem Karadibak
Tuğba Yavuzşen
Tülay Akman
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2639-3

Weitere Artikel der Ausgabe 9/2015

Supportive Care in Cancer 9/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.